lyxumia
sanofi winthrop industrie - lixisenatide - diabetes mellitus, type 2 - drugs used in diabetes, glucagon-like peptide-1 (glp-1) analogues - lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.
suliqua
sanofi winthrop industrie - insulin glargine, lixisenatide - diabetes mellitus, type 2 - legemidler som brukes i diabetes - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sglt-2 inhibitors.
paracet 60 mg
karo pharma as - paracetamol - stikkpille - 60 mg
paracet 500 mg
karo pharma as - paracetamol - brusetablett - 500 mg
paracet 24 mg/ ml
karo pharma as - paracetamol - mikstur, oppløsning - 24 mg/ ml
paracet 250 mg
karo pharma as - paracetamol - smeltetablett med banansmak - 250 mg
paracet 125 mg
karo pharma as - paracetamol - stikkpille - 125 mg
paracet 250 mg
karo pharma as - paracetamol - stikkpille - 250 mg
paracet 500 mg
karo pharma as - paracetamol - stikkpille - 500 mg